FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / pricing-committee-resolutions.docx
pricing-committee-resolutions.docx · 1010-00002

Parties

Arbor Health Technologies Inc
Harkness LLP
Quivorn LLP
Calloway Pierce Securities LLC
Velthorn Capital Partners Inc
Pemberton Wallis LLC
Maximum Gross Proceeds Inc
Associates LLP

Dates

February 8, 2024
October 17, 2023
January 18, 2024
November 10, 2023
December 8, 2023
January 12, 2024
January 22, 2024
February 5, 2024
January 29, 2024
February 7, 2024

Amounts

$0.001
$17.00
$19.00
$18.00
$20.00
$400,000,000
$1.20
$18.80
$24,000,000
$376,000,000

Obligations

Base Gross Proceeds RESOLVED, that the aggregate gross proceeds to the Company from the sale of the Firm Shares at the Public Offering Price shall be $400,000,000 (twenty million shares multiplied by $20
Total Base Underwriting discount RESOLVED, that the aggregate underwriting discount for the Firm Shares shall be $24,000,000 (twenty million shares multiplied by $1
Maximum Gross Proceeds Including Overallotment RESOLVED, that the maximum aggregate gross proceeds from the offering, assuming full exercise of the Overallotment Option, shall be $460,000,000 (twenty-three million shares multiplied by $20
00 per share), and the maximum aggregate underwriting discount shall be $27,600,000 (twenty-three million shares multiplied by $1
Final Prospectus RESOLVED, that the officers of the Company are hereby authorized and directed to prepare (with the assistance of Calderwood & Harkness LLP, as counsel to the Company), finalize, and file with the SEC the final prospectus (the "Final Prospectus") pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended (the "Securities Act"), reflecting the final pricing terms set forth herein, including the Public Offering Price, the number of Firm Shares, the Underwriting discount, the Overallotment Option, and all other terms determined by these resolutions, and that such Final Prospectus shall be filed with the SEC no later than February 9, 2024, in accordance with the timing requirements of Rule 424(b) under the Securities Act; and it is further B
RESOLVED, that these resolutions shall be effective immediately upon adoption by the Committee, and shall remain in full force and effect until amended, modified, or revoked by the Committee or the Board